|
|
NPI Detail
NPI: 1053403402
Type: Organization
Taxonomy Code: 282N00000X
Hospital-General
Hospitals/General Acute Care Hospital
205 X XXXX XXX
JACKSON, MI 492011753
Business phone: (XXX) XXX-XXXX
Mailing address phone: (XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1053403402*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 36415
|
ROUTINE VENIPUNCTURE
|
XXXXX
|
$XXXXX
|
| 85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXXX
|
$XXXXX.XX
|
| 80053
|
COMPREHEN METABOLIC PANEL
|
XXXXX
|
$XXXXXX.X
|
| 80048
|
METABOLIC PANEL TOTAL CA
|
XXXXX
|
$XXXXX.XX
|
| 80061
|
LIPID PANEL
|
XXXXX
|
$XXXXXX.XX
|
| 85610
|
PROTHROMBIN TIME
|
XXXXX
|
$XXXXX.XX
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J0878
|
Daptomycin injection
|
XXXXXX
|
-
|
| J1447
|
Inj tbo filgrastim 1 microg
|
XXXXXX
|
$XXXXX.XX
|
| J1642
|
Inj heparin sodium per 10 u
|
XXXXXX
|
-
|
| J2704
|
Inj, propofol, 10 mg
|
XXXXXX
|
-
|
| J1756
|
Iron sucrose injection
|
XXXXX
|
-
|
| J0256
|
Alpha 1 proteinase inhibitor
|
XXXXX
|
$XXXXXX.XX
|
| J9271
|
Inj pembrolizumab
|
XXXXX
|
$XXXXXXX.XX
|
| J0585
|
Injection,onabotulinumtoxina
|
XXXXX
|
$XXXXXX.XX
|
| J0185
|
Inj., aprepitant, 1 mg
|
XXXXX
|
$XXXXX.XX
|
| J0897
|
Denosumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J9264
|
Paclitaxel protein bound
|
XXXXX
|
$XXXXXX.XX
|
| J9299
|
Injection, nivolumab
|
XXXXX
|
$XXXXXX.XX
|
| J1071
|
Inj testosterone cypionate
|
XXXXX
|
-
|
| J1100
|
Dexamethasone sodium phos
|
XXXXX
|
-
|
| J2001
|
Lidocaine injection
|
XXXXX
|
-
|
| J0881
|
Darbepoetin alfa, non-esrd
|
XXXXX
|
$XXXXX.XX
|
| J9025
|
Azacitidine injection
|
XXXXX
|
$XXXXX.XX
|
| J9263
|
Oxaliplatin
|
XXXXX
|
-
|
| J2405
|
Ondansetron hcl injection
|
XXXXX
|
-
|
| J9267
|
Paclitaxel injection
|
XXXXX
|
-
|
| J2795
|
Ropivacaine hcl injection
|
XXXXX
|
-
|
| J9144
|
Daratumumab, hyaluronidase
|
XXXXX
|
$XXXXXX.XX
|
| J2357
|
Omalizumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J1644
|
Inj heparin sodium per 1000u
|
XXXXX
|
-
|
| J0485
|
Belatacept injection
|
XXXXX
|
$XXXXX.XX
|
| J3262
|
Tocilizumab injection
|
XXXXX
|
$XXXXX.XX
|
| J9047
|
Injection, carfilzomib, 1 mg
|
XXXX
|
$XXXXXX.XX
|
| J9311
|
Inj rituximab, hyaluronidase
|
XXXX
|
$XXXXXX.XX
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0463
|
Hospital outpt clinic visit
|
XXXXX
|
$XXXXXXX.XX
|
| G0378
|
Hospital observation per hr
|
XXXXX
|
-
|
| G1004
|
Cdsm ndsc
|
XXXXX
|
-
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
